Freenome Raises $270M In Series C, Accelerates Trial For Colorectal Cancer Test
Funding will accelerate an FDA registrational study of the company's first liquid biopsy product, as competition increases in early cancer detection.
Funding will accelerate an FDA registrational study of the company's first liquid biopsy product, as competition increases in early cancer detection.